From: Systemic and tumor level iron regulation in men with colorectal cancer: a case control study
 | Cases (n = 20) | Controls (n = 20) | P-value* |
---|---|---|---|
Age | 61.0 (8.0) | 57.5 (12.0) | 0.25 |
BMI | 25.7 (5.0) | 26.9 (7.3) | 0.38 |
WC(cm) | 100.4 (11.5) | 103.3 (18.2) | 0.49 |
Race (%) | Â | Â | Â |
  African American | 50% | 75% | 0.16 |
  White | 30% | 5% |  |
  Hispanic | 5% | 10% |  |
  Asian | 15% | 10% |  |
Dietary iron (grams/day) | Â | Â | Â |
  Heme | 6.7 (4.3) | 7.0 (4.3) | 0.99 |
  Non-heme | 0.67 (0.7) | 0.66 (0.64) | 0.99 |
Alcohol (grams/day) | 0.23 (2.0) | 1.0 (2.1) | 0.46 |
Medications use (yes) | Â | Â | Â |
  Aspirin | 40% | 65% | 0.16 |
  NSAIDs | 50% | 40% | 0.53 |
  COX-2 inhibitors | 10% | 5% | 0.56 |
Cancer staging †|  |  |  |
  I | 15% |  |  |
  II | 40% |  |  |
  III | 30% |  |  |
  IV | 15% |  |  |